Government to seek tariff parity on patented drug exports to US

NEW DELHI: Government plans to raise the issue of the US decision to impose a 100% duty on patented drug imports from India, seeking tariff parity to safeguard the interests of domestic manufacturers. The matter is expected to figure during the trade negotiations with Washington, with New Delhi seeking tariff concessions in line with the UK and countries in the European Union, following industry representation, sources told TOI.

Raccontata datimesofindia.indiatimes.com